ARCHIVES

Avastin doubles progression-free survival in metastatic disease.

This article is from The Cancer Letter archive.

Vol. 31 No. 21 | May 27, 2005

Download PDF Visit The Full Archive

Related Articles

ACS Recommends MRI For Some Women At High Risk

March 30, 2007

New System Devised To Help Identify Emerging Comprehensive Centers

October 10, 1975

Lymphoblastoid If Test Shows Toxicity Not From Impurity, Investigator Says

August 8, 1980

In Brief: Healy Names President, CEO of Red Cross; AMA Supports annual Mammograms for 40+

July 16, 1999

Avastin May Trigger Two FDA Decisions: One On Approval, Another On Withdrawal

September 3, 2010

Immunoassays For Isoenzymes

April 15, 1983